Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens

American Journal of Obstetrics and Gynecology

Volumn 174, Issue 3, 1996, Pages 937-942

  Elfgren, K ^a   Bistoletti, P ^a   Dillner, L ^a   Walboomers, J M M ^a   Meijer, C J L M ^a   Dillner, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

antibodies; cervical intraepithelial neoplasia; Human papillomavirus; loss of human papillomavirus deoxyribonucleic acid; treatment

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX MUCUS; VIRUS INFECTION; WART VIRUS;

EID: 0029881674     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70330-7     Document Type: Article

References (26)

1. MH Schiffman HM Bauer RN Hoover Epidemiological evidence that human papillomavirus infection causes most cervical intraepithelial neoplasia J Natl Cancer Inst 85 1993 958 963
2. H. zur Hausen Viruses in human cancers Science 254 1991 1167 1173
3. AT Lorincz R Reid AB Jenson MD Greenberg WD Lancaster RJ. Kurman Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types Obstet Gynecol 79 1992 328 337
4. L Koutsky KK Holmes CW Critchlow A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection N Engl J Med 327 1992 1272 1278
5. K Syrjänen Factors associated with the clinical behaviour of cervical human papillomavirus infections during a long-term prospective follow-up Br J Obstet Gynaecol 95 1988 1096 1102
6. M Campion DJ McCance J Cuzick A. Singer Progressive potential of mild cervical atypia: prospective cytological, colposcopic and virological study Lancet 2 1986 237 240
7. M Brodman P Dottino F Friedman D Heller I Bleiweiss R. Sperling Human papillomavirus-associated lesions of the vagina and cervix: treatment with a laser and topical 5-fluorouracil J Reprod Med 37 1992 453 456
8. 2-laser vaporization in the treatment of cervical human papillomavirus infection in women with abnormal Papanicolau smears Gynecol Obstet Invest 33 1992 172 176
9. P Bistoletti A Zellbi J Moreno-Lopez A. Hjerpe Genital papillomavirus infection after treatment for cervical intraepithelial neoplasia (CIN). III Cancer 62 1988 2056 2059
10. G Nuovo J Moritz A Kowalik E Chalas B Kaplan W. Mann Human papillomavirus types and cervical squamous intraepithelial lesions that recur after cold-knife conization Gynecol Oncol 46 1992 304 308
11. GJ. Nuovo Human papillomaviruses in recurrent CIN Contemp OB/Gyn 40 1995 9 19
12. GJ. Nuovo BA. Pedemonte Human papillomavirus types and recurrent genital squamous intraepithelial lesions JAMA 263 1990 1223 1227
13. MH. Schiffman Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia J Natl Cancer Inst 84 1992 394 398
14. CJLM Meijer AJC van den Brule PJF Snijders T Helmerhorst P Kenemans JMM. Walboomers Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening N Munoz FX Bosch KV Shah A Meheus The epidemiology of human papillomavirus 1992 IARC Lyon 271 281
15. FX Bosch N Munoz S DeSanjose Risk factors for cervical cancer in Colombia and Spain Int J Cancer 52 1992 750 758
16. J. Dillner Antibody responses to defined HPV epitopes in cervical neoplasia Papillomavirus Report 5 1994 35 41
17. J Dillner P Lenner M Lehtinen A population-based seroepidemiological study of cervical cancer Cancer Res 54 1994 134 141
18. R Kirnbauer NL Hubbert CM Wheeler TM Becker DR Lowy JT. Schiller A virus-like particle ELISA detect serum antibodies in a majority of women infected with human papillomavirus type 16 J Natl Cancer Inst 86 1994 494 498
19. JMM Walboomers PWJ Melkert AJC Van den Brule PJF Snijders CJLM Meijer The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix C Herrington J McGee Diagnostic molecular pathology: a practical approach 2 1992 Oxford University Press Oxford 153 172
20. AJC Van den Brule CJLM Meijer V Bakels P Kenemans JMM. Walboomers Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction J Clin Microbiol 28 1990 2739 2743
21. P Heino C Eklund V Shahnazarian-Fredriksson S Goldman JT Schiller J. Dillner Serum IgG antibodies against human papillomavirus type 16 capsids associated with anal epidermoid carcinoma J Natl Cancer Inst 87 1995 437 440
22. L Dillner A Fredriksson E Persson O Forslund BG Hansson J. Dillner Antibodies against papillomavirus antigens in cervical secretions from condyloma patients J Clin Microbiol 31 1993 192 197
23. GJJ van Doornum M Prins L Pronk RA Coutinho J. Dillner Antibody levels against defined epitopes of human papillomavirus type 16 in relation to genital and anorectal presence of HPV DNA: a prospective study Clin Diagn Lab Immunol 1 1994 633 639
24. JW Sixbey SM Lemon JS. Pagano A second site for Epstein-Barr virus shedding: the uterine cervix Lancet 2 1986 1122 1124
25. A Ferenczy M Mitao N Nagai SJ Silverstein CP. Crum Latent papillomavirus and recurring genital warts N Engl J Med 313 1985 784 788
26. ME Sherman MH Schiffman AT Lorincz Toward objective quality assurance in cervical cytopathology: correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types Am J Clin Pathol 102 1994 182 187